Skip to main content
. Author manuscript; available in PMC: 2016 Feb 10.
Published in final edited form as: Anticancer Drugs. 2016 Mar;27(3):216–224. doi: 10.1097/CAD.0000000000000319

Figure 1. VRL/DVRL concentrations after incubation of 100nM of substrate in HUVEC.

Figure 1

Cells exposed to VRL/DVRL (100nM) for 24h as well as for the metronomic protocol of 96h with daily medium change. Samples collected at the end of the 24h period.